Rare diseases
Investigational molecules
Locations
2503 South Loop Drive Suite 5100, 50010-8641, United States
Lumos Pharma LLC focuses on growth hormone deficiency in paediatric populations, with clinical activity centred on children who are naïve to treatment and those requiring ongoing monitoring for growth-related disorders.
The sponsor’s research interest includes treatment-relevant outcomes in paediatric endocrinology, with emphasis on linear growth and clinical monitoring in children affected by insufficient growth hormone activity.
Lumos Pharma LLC runs clinical trials in conditions such as Congenital growth hormone deficiency, Growth hormone deficiency, among others.
Clinical trials run by this sponsor – those enrolling participants first.
Long-Term Safety Study of LUM-201 (Ibutamoren Mesilate) in Children with Growth Hormone Deficiency
PolandStudy of Daily Oral Ibutamoren Mesilate in Treatment‑Naïve Prepubertal Children with Growth Hormone Deficiency
FranceStudy of the effects of ibutamoren mesilate in prepubertal children with growth hormone deficiency
FranceIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
